A potential estrogen receptor inhibitor compound 34 induces apoptosis via ROS-independent intrinsic apoptosis in MCF-7 cells

Authors

  • Ruru Ding School of Life Sciences, Jiangsu Normal University, Xuzhou 221116, China
  • Ziying Zhu School of Life Sciences, Jiangsu Normal University, Xuzhou 221116, China
  • Mengting Teng School of Life Sciences, Jiangsu Normal University, Xuzhou 221116, China
  • Lin Ma School of Life Sciences, Jiangsu Normal University, Xuzhou 221116, China
  • Jiaying Hu School of Life Sciences, Jiangsu Normal University, Xuzhou 221116, China
  • Jiangbiao Hu School of Chemistry and Chemical Engineering, Jiangsu Normal University, Xuzhou 221116, China.
  • Peng Zhang School of Life Sciences, Jiangsu Normal University, Xuzhou 221116, China

DOI:

https://doi.org/10.3329/bjp.v14i1.38871

Keywords:

Apoptosis, Compound 34, Estrogen receptor, MCF-7 cell

Abstract

This study aimed to investigate the anti-tumor effects of compound 34 on MCF-7 cells in vitro, and explore its mechanisms. MTT results showed that compound 34 selectively inhibited estrogen receptor-positive cells proliferation. Hoechst 33342 staining showed nuclear pyknosis, nuclear debris associated with apoptotic bodies. JC-1 staining showed the loss of mitochondrial membrane potential. Although compound 34 increased intracellular reactive oxygen species (ROS), compound 34-induced apoptosis was not prevented by pretreatment with ROS scavengers. Western blotting showed apoptosis-related protein like cytochrome c and cleaved PARP protein increased. Furthermore, docking studies exhibited that compound 34 could bind into ERα. In summary, compound 34 selectively inhibited estrogen receptor positive cells proliferation and induced apoptosis in MCF-7 cells via ROS-independent intrinsic apoptosis in MCF-7 cells. It may be a potential targeted drug of estrogen receptor for therapeutic application of breast cancer.

Video Clip of Methodology:

Assay of Cell Proliferation: 5 min 5 sec   Click to watch  

Downloads

Download data is not yet available.
Abstract
24
Download
16 Read
3

Downloads

Additional Files

Published

2019-01-07

How to Cite

Ding, R., Z. Zhu, M. Teng, L. Ma, J. Hu, J. Hu, and P. Zhang. “A Potential Estrogen Receptor Inhibitor Compound 34 Induces Apoptosis via ROS-Independent Intrinsic Apoptosis in MCF-7 Cells”. Bangladesh Journal of Pharmacology, vol. 14, no. 1, Jan. 2019, pp. 1-8, doi:10.3329/bjp.v14i1.38871.

Issue

Vol. 14 No. 1 (2019)

Section

Research Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).